Cargando…
Associations between muscle measures, survival, and toxicity in patients with limited stage small cell lung cancer
BACKGROUND: Standard treatment for patients with limited stage small cell lung cancer (LS SCLC) is concurrent platinum–etoposide chemotherapy and thoracic radiotherapy (TRT). Up to 30% of patients are cured, but severe toxicity is common, and we are not able to identify those who are cured or those...
Autores principales: | Halvorsen, Tarje Onsøien, Valan, Christine Damgaard, Slaaen, Marit, Grønberg, Bjørn Henning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567150/ https://www.ncbi.nlm.nih.gov/pubmed/32725772 http://dx.doi.org/10.1002/jcsm.12583 |
Ejemplares similares
-
Associations between severe co‐morbidity and muscle measures in advanced non‐small cell lung cancer patients
por: Grønberg, Bjørn H., et al.
Publicado: (2019) -
Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC
por: Stokke, Kristin, et al.
Publicado: (2022) -
Thoracic Radiotherapy in Limited-Stage SCLC—a Population-Based Study of Patterns of Care in Norway From 2000 Until 2018
por: Graabak, Gustav, et al.
Publicado: (2021) -
Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic
Score in Advanced Non-Small Cell Lung Cancer
por: Stokke, Kristin, et al.
Publicado: (2022) -
Associations between detectable circulating tumor DNA and tumor glucose uptake measured by (18)F-FDG PET/CT in early-stage non-small cell lung cancer
por: Ottestad, Anine Larsen, et al.
Publicado: (2023)